Company

Vitaeris Inc.

Vitaeris Inc., founded in 2016 in Vancouver, develops biotherapeutics for rare diseases and agreed to be acquired by CSL Behring in 2020.

About

Founded in 2016 and headquartered in Vancouver, Canada, Vitaeris Inc. develops biotherapeutics for rare diseases such as hereditary bleeding disorders and immune deficiencies, sold mainly to hospitals and healthcare providers. CSL Behring agreed to acquire the company in June 2020, with financial terms undisclosed. The company has completed 2 deals, the latest a Seed round of USD 7.00 mn led by HBM Partners.

1Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in